Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery Platform
Sponsor : Syneos Health
Deal Size : Undisclosed
Deal Type : Partnership
Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies
Details : The partnership will support the global advancement of cell and gene therapies.The new partnership couples the full suite of clinical development services offered by Syneos Health with IntegriCell™, Cryoport's platform.
Brand Name : Undisclosed
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
January 18, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Sponsor : Syneos Health
Deal Size : Undisclosed
Deal Type : Partnership
LOOKING FOR A SUPPLIER?